Successful treatment of pyoderma gangrenosum with potassium iodide [15]

Acta Dermato-Venereologica

Volumn 86, Issue 1, 2006, Pages 84-85

  Asahina, Akihiko ^a   Minatani, Yohei ^a   Tada, Yayoi ^a   Mitsui, Hiroshi ^a   Tamaki, Kunihiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; DAPSONE; MINOCYCLINE; POTASSIUM IODIDE; PREDNISOLONE; ANTIINFECTIVE AGENT; DERMATOLOGICAL AGENT; GLUCOCORTICOID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADJUVANT THERAPY; ADULT; CASE REPORT; DOSE RESPONSE; DRUG DOSE INCREASE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HUMAN TISSUE; LEG ULCER; LETTER; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; REMISSION; SKIN BIOPSY; TREATMENT OUTCOME; DRUG COMBINATION;

ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DAPSONE; DERMATOLOGIC AGENTS; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; MINOCYCLINE; POTASSIUM IODIDE; PREDNISOLONE; PYODERMA GANGRENOSUM;

MLCS; MLOWN;

EID: 33744726496     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0006      Document Type: Letter

References (14)

1. Ehling A, Karrer S, Klebl F, Schaffler A, Muller-Ladner U. Therapeutic management of pyoderma gangrenosum. Arthritis Rheum 2004; 50: 3076-3084.
2. Callen JP. Pyoderma gangrenosum. Lancet 1998; 351: 581-585.
3. Crowson AN, Mihm MC Jr, Magro C. Pyoderma gangrenosum: a review. J Cutan Pathol 2003; 30: 97-107.
4. Chow RK, Ho VC. Treatment of pyoderma gangrenosum. J Am Acad Dermatol 1996; 34: 1047-1060.
5. Kontochristopoulos GJ, Stavropoulos PG, Gregoriou S, Zakopoulou N. Treatment of pyoderma gangrenosum with low-dose colchicine. Dermatology 2004; 209: 233-236.
6. Sterling JB, Heymann WR. Potassium iodide in dermatology: a 19th century drug for the 21st century - uses, pharmacology, adverse effects, and contraindications. J Am Acad Dermatol 2000; 43: 691-697.
7. Schulz EJ, Whiting DA. Treatment of erythema nodosum and nodular vasculitis with potassium iodide. Br J Dermatol 1976; 94: 75-78.
8. Horio T, Danno K, Okamoto H, Miyachi Y, Imamura S. Potassium iodide in erythema nodosum and other erythematous dermatoses. J Am Acad Dermatol 1983; 9: 77-81.
9. Sanburg AL, Benzie JL. An unusual use for an old drug: potassium iodide in pyoderma gangrenosum. Aust J Hosp Pharm 1987; 17: 187-188.
10. Richardson JB, Callen JP. Pyoderma gangrenosum treated successfully with potassium iodide. J Am Acad Dermatol 1993; 28: 1005-1007.
11. Honma K, Saga K, Onodera H, Takahashi M. Potassium iodide inhibits neutrophil chemotaxis. Acta Derm Venereol 1990; 70: 247-249.
12. Miyachi Y, Niwa Y. Effects of potassium iodide, colchicine and dapsone on the generation of polymorphonuclear leukocyte-derived oxygen intermediates. Br J Dermatol 1982; 107: 209-214.
13. Lear JT, Atherton MT, Byrne JP. Neutrophilic dermatoses: pyoderma gangrenosum and Sweet's syndrome. Postgrad Med J 1997; 73: 65-68.
14. Smith HR, Ashton RE, Beer TW, Theaker JM. Neutrophilpoor Sweet's syndrome with response to potassium iodide. Br J Dermatol 1998; 139: 555-556.